SCHEMBL7143433

SCHEMBL7143433

COc1ccc(-c2nc(-c3ccccc3)c(C)[nH]2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.64
TP53 P04637 3/20 0.64
MAPK13 O15264 1/20 0.64
RAF1 P04049 1/20 0.64
MAPK12 P53778 1/20 0.64
MAPK11 Q15759 1/20 0.64
MAPK14 Q16539 1/20 0.64
SMPD3 Q9NY59 1/20 0.62
KDM4E B2RXH2 5/20 0.60
ALDH1A1 P00352 5/20 0.60
HPGD P15428 4/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
CYP1A2 P05177 1/20 0.60
GLA P06280 1/20 0.60
GAA P10253 1/20 0.60
CYP2C19 P33261 1/20 0.60
GFER P55789 1/20 0.60
NPY5R Q15761 2/20 0.57
HPGDS O60760 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305589 0.87 NPY5R (0.68) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL724250 0.87 NPY5R (0.72) MAPTMAPK13RAF1MAPK12MAPK11
SCHEMBL1132001 0.84 MAPK13 (0.86) MAPTTP53MAPK13RAF1MAPK12
SCHEMBL8104080 0.84 MAPK13 (0.86) MAPTTP53MAPK13RAF1MAPK12
SCHEMBL15400046 0.84 MAPK13 (0.86) MAPTTP53MAPK13RAF1MAPK12
SCHEMBL1308320 0.84 MAPK13 (0.86) MAPTTP53MAPK13RAF1MAPK12
SCHEMBL28763036 0.84 NPY5R (0.74) MAPTTP53MAPK13RAF1MAPK12
SCHEMBL7142762 0.83 NPY5R (0.64) MAPTMAPK13RAF1MAPK12MAPK11
SCHEMBL3760324 0.82 KDM4E (0.73) MAPTTP53MAPK13RAF1MAPK12
SCHEMBL28132421 0.82 POLB (0.78) MAPTTP53MAPK13RAF1MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515133-B1 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. NEUROGEN CORPORATION 2003-02-04 US disclosed
US-6121260-A Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives NEUROGEN CORPORATION (US) 2000-09-19 US disclosed
CN-1265033-A Certain diarylimidaozle derivatives, new class of NPY speific ligands NEUROGEN CORP (US) 2000-08-30 CN disclosed
US-5560785-A TREATING SURFACE WITH SOLUTION OF IMIDAZOLE COMPOUND, COPPER COMPOUND, ZINC COMPOUND, STABILIZERS SHIKOKU CHEMICALS CORPORATION (JP) 1996-10-01 US disclosed
US-5498301-A ON A PRINTED WIRING BOARD, HEAT RESISTANT, MOISTURE RESISTANT, A 2-ARYLIMIDAZOLE, CARBOXYLIC ACID, AMMONIA, WATER SHIKOKU CHEMICALS CORPORATION (JP) 1996-03-12 US disclosed
EP-0627499-A1 Agent for treating surfaces of copper and copper alloys SHIKOKU CHEMICALS CORPORATION (JP) 1994-12-07 EP disclosed